Related references
Note: Only part of the references are listed.Molecular targeted therapy: A new avenue in glioblastoma treatment
Oula El Atat et al.
ONCOLOGY LETTERS (2023)
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial
Andrew B. Lassman et al.
NEURO-ONCOLOGY (2023)
Focused Ultrasound-mediated Drug Delivery in Humans - a Path Towards Translation in Neurodegenerative Diseases
Joanna M. Wasielewska et al.
PHARMACEUTICAL RESEARCH (2022)
Marine Compounds and Cancer: Updates 2022
Sergey A. Dyshlovoy et al.
MARINE DRUGS (2022)
Focused Ultrasound and Microbubbles-Mediated Drug Delivery to Brain Tumor
Sheng-Kai Wu et al.
PHARMACEUTICS (2021)
Genome-wide methylation profiling of glioblastoma cell-derived extracellular vesicle DNA allows tumor classification
Cecile L. Maire et al.
NEURO-ONCOLOGY (2021)
Mutational burden and immune recognition of gliomas
Diego Prost et al.
CURRENT OPINION IN ONCOLOGY (2021)
Tumor Vessels Fuel the Fire in Glioblastoma
Sara Rosinska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
Daniel J. Klionsky et al.
AUTOPHAGY (2021)
Radiation Responses of 2D and 3D Glioblastoma Cells: A Novel, 3D-specific Radioprotective Role of VEGF/Akt Signaling through Functional Activation of NHEJ
Natividad Gomez-Roman et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Marine Compounds and Cancer: The First Two Decades of XXI Century
Sergey A. Dyshlovoy et al.
MARINE DRUGS (2020)
The Role of Rho GTPases in Motility and Invasion of Glioblastoma Cells
Houssam Al-Koussa et al.
ANALYTICAL CELLULAR PATHOLOGY (2020)
Inspired by Sea Urchins: Warburg Effect Mediated Selectivity of Novel Synthetic Non-Glycoside 1,4-Naphthoquinone-6S-Glucose Conjugates in Prostate Cancer
Sergey A. Dyshlovoy et al.
MARINE DRUGS (2020)
Mechanisms and therapeutic implications of hypermutation in gliomas
Mehdi Touat et al.
NATURE (2020)
Autophagy as a Potential Therapy for Malignant Glioma
Angel Escamilla-Ramirez et al.
PHARMACEUTICALS (2020)
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
Aurelien Marabelle et al.
LANCET ONCOLOGY (2020)
N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma
Wolfgang Wick et al.
NEURO-ONCOLOGY (2019)
Survivin is a prognostic indicator in glioblastoma and may be a target of microRNA-218
Xuezhi Tong et al.
ONCOLOGY LETTERS (2019)
Mechanisms of immunotherapy resistance: lessons from glioblastoma
Christopher M. Jackson et al.
NATURE IMMUNOLOGY (2019)
Molecular targeted therapy of glioblastoma
Emilie Le Rhun et al.
CANCER TREATMENT REVIEWS (2019)
Successful Targeting of the Warburg Effect in Prostate Cancer by Glucose-Conjugated 1,4-Naphthoquinones
Sergey A. Dyshlovoy et al.
CANCERS (2019)
Synthesis and anticancer activity of the derivatives of marine compound rhizochalin in castration resistant prostate cancer
Sergey A. Dyshlovoy et al.
Oncotarget (2018)
Frondoside A induces AIF-associated caspase-independent apoptosis in Burkitt lymphoma cells
Sergey A. Dyshlovoy et al.
LEUKEMIA & LYMPHOMA (2017)
Helping EGFR inhibition to block cancer
Rolf Warta et al.
NATURE NEUROSCIENCE (2017)
Proteomic-based investigations on the mode of action of the marine anticancer compound rhizochalinin
Sergey A. Dyshlovoy et al.
PROTEOMICS (2017)
The research on lapatinib in autophagy, cell cycle arrest and epithelial to mesenchymal transition via Wnt/ErK/PI3K-AKT signaling pathway in human cutaneous squamous cell carcinoma
Ming Yao et al.
JOURNAL OF CANCER (2017)
EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise
Manfred Westphal et al.
CNS DRUGS (2017)
InsR/IGF1R Pathway Mediates Resistance to EGFR Inhibitors in Glioblastoma
Yufang Ma et al.
CLINICAL CANCER RESEARCH (2016)
Survival in glioblastoma: a review on the impact of treatment modalities
P. D. Delgado-Lopez et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
Marine compound rhizochalinin shows high in vitro and in vivo efficacy in castration resistant prostate cancer
Sergey A. Dyshlovoy et al.
ONCOTARGET (2016)
Selective Inhibition of Parallel DNA Damage Response Pathways Optimizes Radiosensitization of Glioblastoma Stem-like Cells
Shafiq U. Ahmed et al.
CANCER RESEARCH (2015)
Marine Compounds and Cancer: Where Do We Stand?
Sergey A. Dyshlovoy et al.
MARINE DRUGS (2015)
Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma
David A. Reardon et al.
NEURO-ONCOLOGY (2015)
Inhibition of intracerebral glioblastoma growth by targeting the insulin-like growth factor 1 receptor involves different context-dependent mechanisms
Martin Zamykal et al.
NEURO-ONCOLOGY (2015)
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K
Daniel J. Ma et al.
NEURO-ONCOLOGY (2015)
Quinone-carbohydrate nonglucoside conjugates as a new type of cytotoxic agents: Synthesis and determination of in vitro activity
Dmitry N. Pelageev et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Molecular pathologic diagnosis of epidermal growth factor receptor
Cecile L. Maire et al.
NEURO-ONCOLOGY (2014)
Targeted molecular therapies against epidermal growth factor receptor: Past experiences and challenges
David A. Reardon et al.
NEURO-ONCOLOGY (2014)
Bevacizumab for Newly Diagnosed Glioblastoma Reply
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
EGFR Variant Heterogeneity in Glioblastoma Resolved through Single-Nucleus Sequencing
Joshua M. Francis et al.
CANCER DISCOVERY (2014)
Lapatinib induces autophagic cell death and inhibits growth of human hepatocellular carcinoma
Yu-Jen Chen et al.
ONCOTARGET (2014)
Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Autophagy Stimulates Apoptosis in HER2-Overexpressing Breast Cancers Treated by Lapatinib
Xingmei Zhu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Rational Design of Small Molecule Inhibitors Targeting RhoA Subfamily Rho GTPases
Xun Shang et al.
CHEMISTRY & BIOLOGY (2012)
Proteomic Profiling of Germ Cell Cancer Cells Treated with Aaptamine, a Marine Alkaloid with Antiproliferative Activity
Sergey A. Dyshlovoy et al.
JOURNAL OF PROTEOME RESEARCH (2012)
A Distinct Subset of Glioma Cell Lines with Stem Cell-like Properties Reflects the Transcriptional Phenotype of Glioblastomas and Overexpresses CXCR4 as Therapeutic Target
Alexander Schulte et al.
GLIA (2011)
A Hierarchy of Self-Renewing Tumor-Initiating Cell Types in Glioblastoma
Ruihuan Chen et al.
CANCER CELL (2010)
Marine Two-Headed Sphingolipid-Like Compound Rhizochalin Inhibits EGF-Induced Transformation of JB6 P+ Cl41 Cells
Sergey N. Fedorov et al.
LIPIDS (2009)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria
H. S. Guenther et al.
ONCOGENE (2008)
Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment
Daniel P. Cahill et al.
CLINICAL CANCER RESEARCH (2007)
Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma
D Xie et al.
BRITISH JOURNAL OF CANCER (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification
PD Thomas et al.
NUCLEIC ACIDS RESEARCH (2003)
Share Paper
